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Introduction 
Clinical implications of vascular graft infection vary 
according to the position of the implanted graft. The 
infected aortic bifurcation graft is associated with a 
high incidence of therapeutic failure and also a high 
mortality rate. 1-s In comparison, the mortality rate is 
low following infection of an infrainguinal bypass 
graft, but the risk of major amputation approaches 
80%. 6'7 The close anatomical relation to the perineal 
area and the poor vascularisation of the subcutaneous 
tissue combined with a rich regional lymphatic supply 
predispose the groin to wound infection. Thus, not 
only local contamination, but also haematogenous and 
lymphogenic spread from other infectious ites may 
contribute to the high incidence of infectious com- 
plications in the groin. According to Herbst et al. s 
one out of three graft infections is caused by micro- 
organisms originating from the patient's ischaemic 
ulcer, corroborating the observation by Lorentzen et 
al} that 20% of foot ulcers yield the same micro- 
organism as isolated from the graft. 
Management of infected vascular prostheses i con- 
troversial. One approach is to remove the graft with 
a new extra-anatomic arterial reconstruction i  one or 
two proceduresg; but it is associated with a high level 
of complications and bears a high mortality, especially 
with the involvement of an aortobifemoral graft, s'1°'1~ 
The other approach involves less extensive procedures 
in combination with administration of potent anti- 
biotics.S,6,12 ~5With this approach excellent results have 
been reported even in patients with aortic graft sepsis} 6 
One such antibiotic is gentamicin applied to the region 
of the infection, e.g. the groin. 12'13 In our first reports 
on this treatment, results from 14 and 17 patients, 
respectively, were presented. 12'~3 In this report he num- 
ber of patients has increased to 38 with a follow-up 
period of up to 6 years, mean 13 months. 
* Please address all correspondence to: L. P. Jensen, Department 
of Vascular Surgery 3112, Rigshospitalet, Blegdamsvej 9, DK-2100 
Copenhagen, Denmark. 
Material and Methods 
Since 1989 all patients undergoing vascular surgery in 
our department have been monitored prospectively. 17 
In this study patients from 1989-1993 with graft in- 
fection affecting the groin were included. Some ad- 
ditional information was retrospectively obtained from 
the patient files. Besides patients with primary graft 
infection from our own department, patients referred 
with graft infection from four other vascular de- 
partments covering 2 million inhabitants were also 
included in the study. Twenty female and 28 male 
patients with a median age of 70 years (range 48-89 
years) were included in the study, with a mean follow- 
up time of 13 months. In 40% of the patients the onset 
of infection was within 1 month; in 63% within 3 
months and in 79% within 2 years (Fig. 1). Twenty- 
six patients had an aortofemoral bypass and three an 
axillofemoral bypass to one or both groins. The other 
19 patients had an infrainguinal bypass. 
Patients were treated with either radical excision of 
all prosthetic material or with local wound revision, 
in some cases combined with partial resection of the 
infected prosthesis in the groin or with local graft 
replacement. In 38 patients local treatment included 
systemic antibiotics with a median period of 4 weeks; 
in 32 patients supplemented with local application 
of antibiotics in the form of gentamicin containing 
collagen ]2 or gentamicin beads} 3 
Morbidity was evaluated in terms of recurrent in- 
fections and amputations. Survival data were evalu- 
ated according to the Kaplan-Meier life-table 
method} 8 
Results 
No significant differences in morbidity and mortality 
were detected between patients operated with a supra- 
inguinal or an infrainguinal bypass (Table 1). Ten 
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Fig. 1. Time from primary graft-insertion to the onset of infection in the groin for 48 patients. 
Table 1. Patients operated for graft infection divided according to the anatomic location and to 
the treatment. "Early" indicates within 30 days after the operation. 
Graft Treatment Total 
Aortofemoral Infrainguinal Radical Local Wound 
excision resection revision 
Patients 29 19 10 9 29 48 
Occluded graft at 
time of operation for 
infection 5 6 5 6 0 11 
Early recurrent 
infection 7 3 1 3 6 10 
Late recurrent 
infection 5 2 1 2 4 7 
Early major 
amputation 2 5 3 3 1 7 
Early death 2 0 2 0 0 2 
patients had signs of pan-infection, with septicaemia 
and/or  computed tomography (CT)-verified ab- 
dominal graft involvement, and they were treated with 
total graft excision and concomitant revascularisation. 
The other 38 patients were treated locally in the groin: 
nine with local graft resection or replacement and 29 
with wound revision. Within 30 days of the operation 
two patients died, both in the group treated with 
radical excision. The 3-year survival rate was 47% and 
markedly lower than the expected 87% in a comparable 
age- and sex-matched background population. The 
cause of death could be established in five patients: 
two early deaths were from graft-related septicaemia 
and three late deaths from myocardial infarction (after 
9 months), rnesenteric thrombosis (6 months) and con- 
tinuing graft infection (2 months). Thirty-seven grafts 
were patent at the time of operation, while 11 were 
occluded and treated with either radical excision or 
local resection (Table 1). 
The cultures taken peroperatively revealed Gram- 
positive cocci in 20 patients (41%), intestinal species 
in 20 (41%) and in eight patients (17%) they were 
sterile (Table 2). Recurrent infection occurred in 15 of 
the 38 patients treated locally (37%), in nine within 30 
days and in six at a later stage. Seven recurrent in- 
fections occurred in the 16 patients treated with gen- 
tamicin containing collagen: six in the sixteen patients 
with gentamicin beads and two in the six patients 
without local antibiotics. The treatment of recurrent 
infection included radical excision in six patients, local 
graft resection in five patients and local wound revision 
in three patients. One patient received systemic anti- 
biotics only. Ten patients had need of only one ad- 
ditional revision and five patients up to five repeated 
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Table 2. Bacter io logical  f ind ings  of  cultures taken from the gro in 
at the operat ion.  
Numbers Percent 
Staphylococcus aureus 16 33 
Staphylococcus epidermidis 4 8 
Pseudomonas eruginosa 3 6 
Other monocultures 4 8 
Mixed cultures of intestinal 13 27 
species 
Sterile 8 17 
Total 48 
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Fig. 2. Recurrence-free observation time after the last known revision for 38 patients treated locally in the groin. 
revisions. The mean recurrence-free observation time 
after the final revision were 12 months (Fig. 2). There 
was one death within 30 days of secondary revision. 
Discuss ion  
Management of an infected synthetic graft in the groin 
is complex. The common approach is total graft re- 
moval and a new reconstruction, which can be carried 
out in situ or, in order to avoid the infected area, 
through an extra-anatomic approach. This radical 
treatment bears a high morbidity and mortality in these 
often weakened patients, and a more conservative 
approach is attractive. The results of this study indicate 
that patients without septicaemia or evidence of pan- 
infection benefit from minimal surgical treatment with 
graft preservation and revision in combination with 
both systemic and locally applied antibiotics. Still, 
despite a low mortality, the amputation rate was 26% 
for patients with infrainguinal bypass. 1"6'14 
Powerful broad spectrum systemic antibiotics are 
required for the management of vascular graft in- 
fections. 16 In addition, the application of antibiotics 
within a closed wound after revision of infection is 
possible with gentamycin beads or collagen plates. 12'13 
These therapeutic measures were proven useful but 
not completely satisfactory in the present study, as 
therapeutic failure did become manifest. 6'1°'1s A success 
rate of 50% after 3 years, however, allows for some 
optimism. A median of 2 months between the primary 
operation and manifestation of infection is in ac- 
cordance with the multicentre study from Denmark, ~
while others report a median time to presentation of 
4 months 16 and 41 months in cases of infection with 
Staphylococcus epidermidis. 19 The bacteriological profile 
of the infecting organisms was in accordance with 
that found by others ~'s'4, in that almost half of 
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the infecting organisms were Gram-positive cocci and 
17% were sterile cultures. 
Conclusion 
A conservative approach including wound revision 
and antibiotics applied both systemically and locally is 
preferable as the first choice in patients with prosthetic 
infection in the groin without evidence of pan- 
infection. 
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